Highlights from Health Sector: Key Developments and Updates

A roundup of current health news includes FDA's potential reassessment of a Duchenne drug, U.S. court decisions impacting gender care, Congo's Ebola outbreak, and U.S. hospital billing issues. Reports highlight market shifts in consumer demands for healthier ice cream and the growing concern over healthcare in conflict zones.

In recent health sector developments, the FDA may reconsider its stance on Capricor's Duchenne drug following a prior negative vote. This review has revitalized investor interest, sending the company's shares soaring by 70%.

Meanwhile, the Democratic Republic of Congo reports a new province impacted by the Ebola virus, indicating a worrying trend of wider transmission across the region. This case, involving a motorcycle taxi driver, underscores the threat posed by mobile exposures amid outbreaks.

In the U.S., significant decisions are shaping the landscape of gender-affirming care and medical billing practices. The Trump administration's new rule restricts federal funding for gender care, while a federal court ruling has invalidated a formula intended to curb exorbitant 'surprise' medical bills.